RiverGlades Family Offices LLC
Family OfficePosition in LLY — ELI LILLY & Co
CIK 1619779
NAPLES, FL
Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$538,544
New position
Shares Held
449
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#3,699
of 4,605 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 45%
Shared 0%
None 55%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RiverGlades Family Offices LLC holds $899,000 across 2 Drug Manufacturers - General names. LLY ranks #1 (59.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
449 | $538,544 | |
| 2 | NVS |
Novartis AG
|
2,300 | $360,456 |
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,544 | 449 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||